Presentation is loading. Please wait.

Presentation is loading. Please wait.

Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.

Similar presentations


Presentation on theme: "Are We There Yet ? Abdul H. Sankari, MD FACC FCCP."— Presentation transcript:

1 Are We There Yet ? Abdul H. Sankari, MD FACC FCCP

2 Screening, defined Screening is a process that aims to identify disease prior to the point of clinical presentation in order to intervene more effectively

3 CVD vs Cancer mortality In 2002 657,000 death from MI and stroke Vs 557,000 from all cancers. Still screening for occult Breast, Colon, and breast cancer has become a widley accepted public policy, but screening for atherosclerosis (the leading cause of CHD and Stroke) has not.

4 Traditional Risk Assessment models Framingham Risk Score Systemic Coronary Risk Evaluation (SCORE) A 10 years probability of developing CAD, Based on Gender, Age, BP, Lipids, and Smoking history

5 LIMITATIONS Poor sensitivity (36% for women and 74% for men) Compared with 97 and 98% for calcium scoring Will allow for recognition of a very high or very low risk patients, however, the Intermediate risk group (where most Heart attacks and Stroke will occur)is poorly recognized.

6 LIMITATIONS 2 In the US the prevelance of more than one risk factor is very High among indivisuals over 40y of age who develop CHD, but also very high in indivisuals that don’t

7 How to properly Screen Identify Abnormal Arterial structure and function (Vulnerable patient /Vulnerable Myocardium/ vulnerable Blood/ Vulnerable plaque) Guidelines New screening tools Coronary Calcium score CIMT ABI CRP

8 WHY SCREEN CHD is the leading cause of mortality in men & women causing more than 1 in 5 deaths An estimated 875,000 will have their first heart attack annually and 500,000 will have a recurrent MI Stroke is the number 3 cause of mortality and the leading cause of long term disability An estimated 700,000 will have a stroke annually

9 SHAPE recommendations All men 45-75 y and women 55-75 should undergo screening

10 Very high High Risk Moderate risk

11 Low Risk CACS = 0 CIMT < 50 th percentile, no carotid plaque

12 Moderate Risk CACS = 0 CIMT < 50 th percentile Have Traditional Risk factors

13 Moderatly High Risk CACS = 1-100 CIMT < 1mm. 51-75 th percentile---no plaque

14 High Risk CACS = 101-399 Cimt > 1mm or > 75 th percentile

15 Very High Risk CACS > 400 CIMT : Carotid plaque with > 50% stenosis


Download ppt "Are We There Yet ? Abdul H. Sankari, MD FACC FCCP."

Similar presentations


Ads by Google